Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · IEX Real-Time Price · USD
43.50
+0.50 (1.16%)
May 3, 2024, 12:01 PM EDT - Market open

Xenon Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
259
Market Cap
3.28B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20229.43M-9.00M-48.83%
Dec 31, 202118.44M-13.73M-42.68%
Dec 31, 202032.17M25.34M371.02%
Dec 31, 20196.83M--
Dec 31, 20180--
Dec 31, 2017311.00K-1.49M-82.75%
Dec 31, 20161.80M-13.77M-88.43%
Dec 31, 201515.58M-12.79M-45.09%
Dec 31, 201428.37M1.01M3.71%
Dec 31, 201327.36M13.05M91.19%
Dec 31, 201214.31M7.39M106.82%
Dec 31, 20116.92M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.76B
Fortrea Holdings 3.11B
Surgery Partners 2.74B
Evolent Health 1.96B
Progyny 1.09B
Sotera Health Company 1.05B
HUTCHMED (China) 838.00M
10x Genomics 625.45M
Revenue Rankings